Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update
Position
Chief Executive Officer
Company
Chemomab Therapeutics Ltd
Tel AvivBiotechnologyHealth CareTherapeuticsDescription
─Sigal Fattal, Vice President Finance, Reappointed as CFO─","─Nissim Darvish, MD, PhD, Appointed Chairman of the Board─","Chemomab Therapeutics Ltd. , a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced changes to its executive leadership team and provided a corporate update.","Adi Mor, PhD, co-Founder and former Chief Executive Officer of Chemomab, and current Director and Chief Scientific Officer, has been reappointed to the role of CEO, replacing Dale Pfost, PhD. Sigal Fattal, former Chief Financial Officer and current Vice President, Finance, has been reappointed to the role of CFO, replacing Donald Marvin
Quick answer
Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update (June 5, 2023). Chemomab Therapeutics Ltd is based in Tel Aviv, Tel Aviv District, Israel.
- What did Chemomab Therapeutics Ltd announce on June 5, 2023?
- ─Sigal Fattal, Vice President Finance, Reappointed as CFO─","─Nissim Darvish, MD, PhD, Appointed Chairman of the Board─","Chemomab Therapeutics Ltd. , a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced changes to its executive leadership team and provided a corporate update.","Adi Mor,...
- What does Chemomab Therapeutics Ltd do?
- Chemomab is a clinical stage biotechnology company discovering and developing innovative therapeutics for fibro-inflammatory diseases with high unmet need.
- Where is Chemomab Therapeutics Ltd based?
- Chemomab Therapeutics Ltd is based in Tel Aviv, Tel Aviv District, Israel.
- Which similar companies made leadership changes around the same time?
- Visgenx, Inc. (June 5, 2023), MRM Health (June 7, 2023), BehaVR (June 8, 2023) and LumaBridge (May 31, 2023) also announced leadership changes within 45 days of Chemomab Therapeutics Ltd.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Visgenx Appoints William Pedranti as Chief Executive Officer (June 5, 2023)
- MRM Health Appoints Katja Conrath as Chief Scientific Officer (June 7, 2023)
- BehaVR Appoints Former Pear Therapeutics, TytoCare and AVIA Executives to Senior Leadership Team (June 8, 2023)
- Todd Lehman Joins LumaBridge as Vice President and Head of Business Development (May 31, 2023)
- Juha Punnonen, M.D., Ph.D. Joins Hinge Bio as Chief Development Officer (May 31, 2023)
- Phanes Therapeutics announces the appointment of Rita Laeufle, MD, PhD, as Chief Medical Officer (May 30, 2023)
Who to call at Chemomab Therapeutics Ltd, and when
A new leader at Chemomab Therapeutics Ltd brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Chemomab Therapeutics Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Chemomab Therapeutics Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Chemomab Therapeutics Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Chemomab Therapeutics Ltd changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Chemomab Therapeutics Ltd changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.